Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer

This publication has 34 references indexed in Scilit:

• MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery
  International Journal of Pharmaceutics, 2014
• Stable RNA nanoparticles as potential new generation drugs for cancer therapy
  Advanced Drug Delivery Reviews, 2014
• Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin
  Colloids and Surfaces B: Biointerfaces, 2010
• hSET1: A novel approach for colon cancer therapy
  Biochemical Pharmacology, 2009
• Knocking down barriers: advances in siRNA delivery
  Nature Reviews Drug Discovery, 2009
• RNA interference: Implications for cancer treatment
  Molecular Aspects of Medicine, 2007
• Histone H3 Lys 4 methylation: caught in a bind?
  Genes & Development, 2006
• Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing
  Cell, 2005
• Global Loss of Set1-mediated H3 Lys4 Trimethylation Is Associated with Silencing Defects in Saccharomyces cerevisiae
  Journal of Biological Chemistry, 2005
• Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
  The Journal of Pathology, 2001